Ayurveda Rasayana as antivirals and immunomodulators: potential applications in COVID-19

被引:0
作者
Rajeshwari Singh
Sumeet Goel
Pascale Bourgeade
Lotfi Aleya
Devesh Tewari
机构
[1] Government of India,Central Council for Research in Ayurvedic Sciences, Ministry of AYUSH
[2] Bourgogne Franche-Comté University,Chrono
[3] Lovely Professional University,Environnement Laboratory, UMR CNRS 6249
来源
Environmental Science and Pollution Research | 2021年 / 28卷
关键词
AYUSH; Antiviral; Immunity; Traditional medicine; Repurposing;
D O I
暂无
中图分类号
学科分类号
摘要
Coronavirus disease (COVID-19) has been declared as a pandemic by the World Health Organization with rapid spread across 216 countries. COVID-19 pandemic has left its imprints on various health systems globally and caused immense social and economic disruptions. The scientific community across the globe is in a quest for digging the effective treatment for COVID-19 and exploring potential leads from traditional systems of healthcare across the world too. Ayurveda (Indian traditional system of medicine) has a comprehensive aspect of immunity through Rasayana which is a rejuvenation therapy. Here we attempt to generate the potential leads based on the classical text from Ayurveda in general and Rasayana in particular to develop effective antiviral and/or immunomodulator for potential or adjunct therapy in SARS-CoV-2. The Rasayana acts not only by resisting body to restrain or withstand the strength, severity or progression of a disease but also by promoting power of the body to prevent the manifestation of a disease. These Rasayana herbs are common in practice as immunomodulator, antiviral and protectives. The studies on Rasayana can provide an insight into the future course of research for the plausible development of effective management of COVID-19 by the utilization and development of various traditional systems of healthcare. Keeping in view the current pandemic situation, there is an urgent need of developing potential medicines. This study proposes certain prominent medicinal plants which may be further studied for drug development process and also in clinical setup under repurposing of these herbs.
引用
收藏
页码:55925 / 55951
页数:26
相关论文
共 1285 条
  • [1] Afolayan FID(2015)Scientific opinion on the safety and efficacy of glycyrrhizic acid ammoniated (chemical group 30, miscellaneous substances) when used as a flavouring for all animal species EFSA J 13 3971-175
  • [2] Erinwusi B(2018)Immunomodulatory activity of curcumin-entrapped poly d,l-lactic-co-glycolic acid nanoparticles in mice Integr Med Res 7 168-8964814
  • [3] Oyeyemi OT(2016)A review on potential mechanisms of Adv Pharmacol Sci 2016 8964849-604
  • [4] Afshari AR(2016) in Alzheimer’s disease Mol Med Rep 13 592-178
  • [5] Sadeghnia HR(2021)Systematic and comprehensive investigation of the toxicity of curcuminoid-essential oil complex: a bioavailable turmeric formulation Front. Pharmacol. 11 2470-2934512
  • [6] Mollazadeh H(2016)Indian medicinal plants and formulations and their potential against COVID-19–preclinical and clinical research J Pharm Investig 46 169-1049
  • [7] Aggarwal LM(2018)The physicochemical, safety and antimicrobial properties of Phyllanthus amarus herbal cream and ointment Evidence-Based Complement Altern Med 2018 2934583-645
  • [8] Chacko MK(2002)Antimycobacterial activity and safety profile assessment of Planta Med. 68 1047-251
  • [9] Kuruvilla TB(2019) and Front. Cell Dev. Biol. 7 154-276
  • [10] Ahmad S(2015)Tracheospasmolytic activity of viteosin-A and vitexicarpin isolated from vitex trifolia Am J PharmTech Res 5 638-303